rs376663459
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_015386.3(COG4):c.529C>T(p.Arg177*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015386.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COG4 | NM_015386.3 | c.529C>T | p.Arg177* | stop_gained | Exon 4 of 19 | ENST00000323786.10 | NP_056201.2 | |
COG4 | NM_001195139.2 | c.517C>T | p.Arg173* | stop_gained | Exon 4 of 18 | NP_001182068.2 | ||
COG4 | NM_001365426.1 | c.103C>T | p.Arg35* | stop_gained | Exon 5 of 20 | NP_001352355.1 | ||
COG4 | NR_158212.1 | n.540C>T | non_coding_transcript_exon_variant | Exon 4 of 19 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152018Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251420 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461852Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727232 show subpopulations
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152018Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74246 show subpopulations
ClinVar
Submissions by phenotype
COG4-congenital disorder of glycosylation Pathogenic:2Other:1
Variant classified as Likely pathogenic and reported on 06-17-2021 by GeneDx. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
The Arg177X variant in COG4 has not been previously reported in individuals with congenital disorders of glycosylation or in large population studies. This nonsense variant leads to a premature termination codon at position 177 which is predicted to lead to a truncated or absent protein. Loss-of-function variants in COG4 have been described in individuals with congenital disorder of glycosylation type II (Reynders 2009, Ng 2011). In summary, although additional studies are required to fully establish its clinical significance, theArg177X variant is likely pathogenic. -
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000208568). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at